Literature DB >> 35110680

The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation.

Yangfan Xu1,2, Xiaoyu He1,2, Shanzheng Wang3,4,5, Baofa Sun3,4,5,6, Ruobing Jia1,2, Peiwei Chai1,2, Fang Li1,2, Ying Yang3,4,5,6, Shengfang Ge1,2, Renbing Jia1,2, Yun-Gui Yang7,8,9,10, Xianqun Fan11,12.   

Abstract

N6-methyladenosine (m6A) is the most universal internal RNA modification on messenger RNAs and regulates the fate and functions of m6A-modified transcripts through m6A-specific binding proteins. Nevertheless, the functional role and potential mechanism of the m6A reading proteins in ocular melanoma tumorigenicity, especially cancer stem-like cell (CSC) properties, remain to be elucidated. Herein, we demonstrated that the m6A reading protein YTHDF3 promotes the translation of the target transcript CTNNB1, contributing to ocular melanoma propagation and migration through m6A methylation. YTHDF3 is highly expressed in ocular melanoma stem-like cells and abundantly enriched in ocular melanoma tissues, which is related to poor clinical prognosis. Moreover, YTHDF3 is required for the maintenance of CSC properties and tumor initiation capacity in ocular melanoma both in vitro and in vivo. Ocular melanoma cells with targeted YTHDF3 knockdown exhibited inhibitory tumor proliferation and migration abilities. Transcriptome-wide mapping of m6A peaks and YTHDF3 binding peaks on mRNAs revealed a key target gene candidate, CTNNB1. Mechanistically, YTHDF3 enhances CTNNB1 translation through recognizing and binding the m6A peaks on CTNNB1 mRNA.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35110680     DOI: 10.1038/s41388-021-02146-0

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

Review 1.  The Biology of m6A RNA Methylation in Normal and Malignant Hematopoiesis.

Authors:  Ly P Vu; Yuanming Cheng; Michael G Kharas
Journal:  Cancer Discov       Date:  2018-12-21       Impact factor: 39.397

Review 2.  RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.

Authors:  Yanan Yue; Jianzhao Liu; Chuan He
Journal:  Genes Dev       Date:  2015-07-01       Impact factor: 11.361

3.  Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome.

Authors:  Bastian Linder; Anya V Grozhik; Anthony O Olarerin-George; Cem Meydan; Christopher E Mason; Samie R Jaffrey
Journal:  Nat Methods       Date:  2015-06-29       Impact factor: 28.547

Review 4.  Epitranscriptomic influences on development and disease.

Authors:  Phillip J Hsu; Hailing Shi; Chuan He
Journal:  Genome Biol       Date:  2017-10-23       Impact factor: 13.583

Review 5.  Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism.

Authors:  Ying Yang; Phillip J Hsu; Yu-Sheng Chen; Yun-Gui Yang
Journal:  Cell Res       Date:  2018-05-22       Impact factor: 25.617

6.  m6A facilitates hippocampus-dependent learning and memory through YTHDF1.

Authors:  Hailing Shi; Xuliang Zhang; Yi-Lan Weng; Hongjun Song; Chuan He; Tao Zhou; Zongyang Lu; Yajing Liu; Zhike Lu; Jianan Li; Piliang Hao; Yu Zhang; Feng Zhang; You Wu; Jary Y Delgado; Yijing Su; Meera J Patel; Xiaohua Cao; Bin Shen; Xingxu Huang; Guo-Li Ming; Xiaoxi Zhuang
Journal:  Nature       Date:  2018-10-31       Impact factor: 49.962

7.  m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade.

Authors:  Seungwon Yang; Jiangbo Wei; Yan-Hong Cui; Gayoung Park; Palak Shah; Yu Deng; Andrew E Aplin; Zhike Lu; Seungmin Hwang; Chuan He; Yu-Ying He
Journal:  Nat Commun       Date:  2019-06-25       Impact factor: 14.919

8.  Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.

Authors:  Jasmin Paris; Marcos Morgan; Joana Campos; Gary J Spencer; Alena Shmakova; Ivayla Ivanova; Christopher Mapperley; Hannah Lawson; David A Wotherspoon; Catarina Sepulveda; Milica Vukovic; Lewis Allen; Annika Sarapuu; Andrea Tavosanis; Amelie V Guitart; Arnaud Villacreces; Christian Much; Junho Choe; Ali Azar; Louie N van de Lagemaat; Douglas Vernimmen; Ali Nehme; Frederic Mazurier; Tim C P Somervaille; Richard I Gregory; Dónal O'Carroll; Kamil R Kranc
Journal:  Cell Stem Cell       Date:  2019-04-25       Impact factor: 24.633

9.  m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation.

Authors:  Ruobing Jia; Peiwei Chai; Shanzheng Wang; Baofa Sun; Yangfan Xu; Ying Yang; Shengfang Ge; Renbing Jia; Yun-Gui Yang; Xianqun Fan
Journal:  Mol Cancer       Date:  2019-11-14       Impact factor: 27.401

10.  DART-seq: an antibody-free method for global m6A detection.

Authors:  Kate D Meyer
Journal:  Nat Methods       Date:  2019-09-23       Impact factor: 28.547

View more
  3 in total

1.  N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability.

Authors:  Deyin Liu; Zhong Li; Kun Zhang; Daigang Lu; Dawei Zhou; Yibin Meng
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-28       Impact factor: 4.322

Review 2.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

3.  ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators.

Authors:  Zhonglin Cai; Huan Xu; Gang Bai; Hanjing Hu; Di Wang; Hongjun Li; Zhong Wang
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.